CN112741789A - Anti-aging composition, preparation method and application - Google Patents
Anti-aging composition, preparation method and application Download PDFInfo
- Publication number
- CN112741789A CN112741789A CN202011555137.5A CN202011555137A CN112741789A CN 112741789 A CN112741789 A CN 112741789A CN 202011555137 A CN202011555137 A CN 202011555137A CN 112741789 A CN112741789 A CN 112741789A
- Authority
- CN
- China
- Prior art keywords
- aging composition
- aging
- skin
- composition according
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 26
- FCGXLCNBWYIEAA-UHFFFAOYSA-N 1,3-benzothiazol-6-ylmethanamine Chemical compound NCC1=CC=C2N=CSC2=C1 FCGXLCNBWYIEAA-UHFFFAOYSA-N 0.000 claims abstract description 17
- 244000258095 Salvia lavandulifolia Species 0.000 claims abstract description 17
- 235000001500 Salvia lavandulifolia Nutrition 0.000 claims abstract description 17
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- -1 ceteareth-20 Chemical compound 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- 239000004386 Erythritol Substances 0.000 claims description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims description 4
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 4
- 229940036350 bisabolol Drugs 0.000 claims description 4
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 4
- 229940009714 erythritol Drugs 0.000 claims description 4
- 235000019414 erythritol Nutrition 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 4
- 229940032094 squalane Drugs 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 235000010384 tocopherol Nutrition 0.000 claims description 4
- 229960001295 tocopherol Drugs 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 3
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 3
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 3
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 229920002498 Beta-glucan Polymers 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 241000206575 Chondrus crispus Species 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- 108010024636 Glutathione Proteins 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 claims description 3
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 235000021302 avocado oil Nutrition 0.000 claims description 3
- 239000008163 avocado oil Substances 0.000 claims description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 3
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 229940073669 ceteareth 20 Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229960003993 chlorphenesin Drugs 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims description 3
- 229920006037 cross link polymer Polymers 0.000 claims description 3
- 229940086555 cyclomethicone Drugs 0.000 claims description 3
- PDYOTPOJFZAOIS-UHFFFAOYSA-N decanoic acid;2,2-dimethylpropane-1,3-diol;octanoic acid Chemical compound OCC(C)(C)CO.CCCCCCCC(O)=O.CCCCCCCCCC(O)=O PDYOTPOJFZAOIS-UHFFFAOYSA-N 0.000 claims description 3
- 230000023753 dehiscence Effects 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 239000010776 emu oil Substances 0.000 claims description 3
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 229960003180 glutathione Drugs 0.000 claims description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 3
- 229960001915 hexamidine Drugs 0.000 claims description 3
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 3
- 229940031575 hydroxyethyl urea Drugs 0.000 claims description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229940101267 panthenol Drugs 0.000 claims description 3
- 235000020957 pantothenol Nutrition 0.000 claims description 3
- 239000011619 pantothenol Substances 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 3
- 229940068977 polysorbate 20 Drugs 0.000 claims description 3
- 229940113124 polysorbate 60 Drugs 0.000 claims description 3
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 claims description 3
- 229960003415 propylparaben Drugs 0.000 claims description 3
- 229940064064 purslane extract Drugs 0.000 claims description 3
- 229940094944 saccharide isomerate Drugs 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229940083542 sodium Drugs 0.000 claims description 3
- 229940047670 sodium acrylate Drugs 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 229940035437 1,3-propanediol Drugs 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- 244000124209 Crocus sativus Species 0.000 claims description 2
- 235000015655 Crocus sativus Nutrition 0.000 claims description 2
- 229960004217 benzyl alcohol Drugs 0.000 claims description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 229940113120 dipropylene glycol Drugs 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 229940075495 isopropyl palmitate Drugs 0.000 claims description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960002216 methylparaben Drugs 0.000 claims description 2
- 239000003607 modifier Substances 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 235000013974 saffron Nutrition 0.000 claims description 2
- 239000004248 saffron Substances 0.000 claims description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 claims 1
- 229940116224 behenate Drugs 0.000 claims 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229940080812 glyceryl caprate Drugs 0.000 claims 1
- 229940087068 glyceryl caprylate Drugs 0.000 claims 1
- 229940100573 methylpropanediol Drugs 0.000 claims 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims 1
- 239000003229 sclerosing agent Substances 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000009965 odorless effect Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 description 25
- 238000012360 testing method Methods 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 230000036548 skin texture Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 239000000686 essence Substances 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 5
- 230000001153 anti-wrinkle effect Effects 0.000 description 4
- 235000020235 chia seed Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000017276 Salvia Nutrition 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 2
- PBWGCNFJKNQDGV-UHFFFAOYSA-N 6-phenylimidazo[2,1-b][1,3]thiazol-5-amine Chemical compound N1=C2SC=CN2C(N)=C1C1=CC=CC=C1 PBWGCNFJKNQDGV-UHFFFAOYSA-N 0.000 description 2
- 241001530056 Athelia rolfsii Species 0.000 description 2
- 241001072909 Salvia Species 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 229940090958 behenyl behenate Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000000216 zygoma Anatomy 0.000 description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000001691 salvia sclarea Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to the field of skin care products, and particularly discloses an anti-aging composition, a preparation method and application, wherein the anti-aging composition comprises the following components in percentage by mass: 1-10% of Spanish sage seed extract and 1-5% of isosorbide dimethyl ether. Under the compound scheme provided by the invention, the isosorbide dimethyl ether can promote the transdermal absorption of the spanish sage seed extract and enhance the repairing and anti-aging effects of the spanish sage seed extract. Meanwhile, the isosorbide dimethyl ether is colorless and odorless liquid, so that the skin care product applied on the skin cannot generate unpleasant odor and influence the skin color.
Description
Technical Field
The invention relates to the field of skin care products, in particular to an anti-aging composition, a preparation method and application.
Background
Aging is an inevitable natural law in the life process, and as a first barrier of a human body, the skin is aged all the time, the elasticity of the skin is slowly reduced, the skin becomes thinner and weaker, and the skin becomes loose and wrinkled with visual impression. Skin aging is generally natural aging and photoaging. The former mainly refers to aging caused by non-resistant factors existing in the body such as heredity, gravity, endocrine and immune functions with the aging; the latter is mainly due to the action of ultraviolet rays, which accelerates the process of natural aging.
Skin aging is the prevention of gradual functional and degenerative changes of the skin over time, mainly the prevention of sagging and wrinkles. The anti-aging cosmetics are cosmetics for realizing anti-aging effect, are one of important functional cosmetics, are many in the current market, but most of the anti-aging cosmetics have unobvious effect, cannot meet the requirements of consumers, and are difficult to absorb by skin. Therefore, the invention of an anti-aging composition with good absorption effect and effectiveness is a problem to be solved urgently.
Disclosure of Invention
The first purpose of the invention is to provide an anti-aging composition, which solves the problem that the anti-aging products on the market have poor absorption effect and anti-aging effect.
In order to achieve the purpose, the invention adopts the following technical scheme:
an anti-aging composition, comprising by mass percent: 1-10% of a Xiban salvia seed extract and 1-5% of isosorbide dimethyl ether.
Further, the anti-aging composition also comprises an emulsifier, and the anti-aging composition also comprises an emulsifier, wherein the emulsifier comprises one or more of polyglycerol-10 dipalmitate, hydrogenated lecithin, PEG-20 behenyl behenate, potassium cetyl phosphate, ceteareth-20, sucrose stearate, polysorbate-60, polysorbate-20, PEG-40 hydrogenated castor oil, PEG-50 hydrogenated castor oil, caprylic/capric glyceride polyglycerol-10 ester.
Further, the anti-aging composition also comprises a thickening agent, wherein the thickening agent comprises one or more of hydroxyethyl cellulose, carbomer, xanthan gum, sodium acrylate/sodium acryloyldimethyl taurate copolymer, polyacrylate cross-linked polymer-6, ammonium acryloyldimethyl taurate/behenyl alcohol polyether-25 methacrylate cross-linked polymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sclerotium rolfsii gum, carrageen powder and agarose.
Further, the anti-aging composition further comprises an emollient comprising one or more of cetyl stearyl alcohol, squalane, isopropyl palmitate, ethylhexyl palmitate, dimethicone, cyclomethicone, octyl methicone, caprylic/capric triglyceride, isocetyl, mineral oil, oat kernel oil, octyldodecanol, avocado oil, emu oil, isopropyl myristate, saffron oil, neopentyl glycol dicaprylate/dicaprate.
Further, the anti-aging composition also comprises a humectant which comprises one or more of glycerin, butanediol, 1, 3-propylene glycol, betaine, dipropylene glycol, glyceryl polyether-26, erythritol, methyl propylene glycol, hydroxyethyl urea, sodium polyglutamate, panthenol, levan and trehalose.
Further, the anti-aging composition further comprises a skin conditioning agent comprising one or more of bisabolol, tocopherol, beta-glucan, niacinamide, biogum-1, glycerol glucoside, polyquaternium-51, glutathione, saccharide isomerate, purslane extract, avenin, acetyl chitosamine, lactic acid bacteria fermentation lysate, yeast dehiscence lysate.
Further, the anti-aging composition also comprises a ph regulator, wherein the ph regulator comprises one or more of triethanolamine, potassium hydroxide, arginine, sodium hydroxide, citric acid and sodium citrate.
Further, the anti-aging composition also comprises a preservative, wherein the preservative comprises one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, chlorphenesin, phenoxyethanol, ethylhexyl glycerol, hexamidine dihydrochloride and benzyl alcohol.
A second object of the present invention is to provide a method for preparing the antiaging composition as described above, which comprises a step of mixing the components of the antiaging composition.
The third purpose of the invention is to provide the application of the anti-aging composition in skin care products, wherein the skin care products comprise water-type skin care products, gel-type skin care products, emulsion-type skin care products or cream-type skin care products.
The invention has the beneficial effects that:
the invention provides an anti-aging composition, which comprises the following components in percentage by mass: 1-10% of Spanish sage seed extract and 1-5% of isosorbide dimethyl ether. Under the compound scheme provided by the invention, the isosorbide dimethyl ether can promote the transdermal absorption of the spanish sage seed extract and enhance the repairing and anti-aging effects of the spanish sage seed extract. Meanwhile, the isosorbide dimethyl ether is colorless and odorless liquid, and does not cause the skin care product applied on the skin to generate unpleasant odor and influence the skin color.
Detailed Description
The invention provides an anti-aging cosmetic composition and a preparation method and application thereof. In order that the invention may be more readily understood, reference will now be made to the following more particular description of the invention taken in conjunction with the accompanying examples, wherein like reference numerals refer to like parts throughout. The invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. These embodiments are provided so that this disclosure will be thorough and complete. All types of raw materials used in the examples are, unless otherwise specified, common commercial products.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
The numerical values set forth in the examples of the present invention are approximations, not necessarily values. All values within the error range may be included without limiting the specific values disclosed in the embodiments of the present invention, where the error or experimental conditions allow.
The numerical ranges disclosed in the examples of the present invention are intended to indicate the relative amounts of the components in the mixture and the ranges of temperatures or other parameters recited in the other method examples.
The invention provides an anti-aging composition, which comprises the following components in percentage by mass: 1-10% of Spanish sage seed extract and 1-5% of isosorbide dimethyl ether.
In this example, the extract of the seeds of Spanish sage is available under the trade name Phytouse Rejuvenanate and is a product of Active receptors, USA. The extract of Salvia Spanish seed contains a large amount of polysaccharide, has good film forming and moisture keeping effects, and can promote cell regeneration and keep skin young and elastic. The extract of Salvia Spanish seed is polysaccharide obtained by separating mucus through special process, and fermenting. The polysaccharide is helpful for cell proliferation, wound healing, and collagen synthesis. Can repair the tiny wound of the skin caused by environmental exposure, strengthen the barrier function of the skin and delay the aging of the skin. Therefore, the composition developed by extracting the extract of the salvia sclarea can be widely applied to skin care products to achieve excellent anti-aging effect.
Although the anti-aging effect can be achieved by adding the extract of the chia seed into the anti-aging composition, the anti-aging effect which can be achieved by applying the anti-aging composition prepared by only using the extract of the chia seed into the skin care product is limited, because the extract of the chia seed is rich in macromolecular polysaccharide, is difficult to penetrate through the skin and be absorbed by the human body, and cannot exert the effect of the extract of the chia seed to the maximum extent, therefore, in order to improve the problem, the anti-aging composition is also added with isosorbide dimethyl ether which is colorless and tasteless liquid, can dissolve free fat in the skin, can effectively penetrate through a skin membrane, can enhance the conveying capacity of other components in a cosmetic formula, thereby enhancing the using effect of the cosmetic, and is colorless and tasteless, does not cause the skin care product smeared on the skin to generate unpleasant smell and influence the skin color. So that the anti-aging composition provided by the invention has more excellent anti-aging effect.
In a further embodiment of the present invention, the antiaging composition further comprises an emulsifier, the emulsifier comprising one or more of polyglycerol-10 dipalmitate, hydrogenated lecithin, PEG-20 behenyl behenate, potassium cetyl phosphate, ceteareth-20, sucrose stearate, polysorbate-60, polysorbate-20, PEG-40 hydrogenated castor oil, PEG-50 hydrogenated castor oil, caprylic/capric glyceride polyglycerol-10 esters. The addition amount of the emulsifier is 0.1-5.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a thickener comprising one or more of hydroxyethylcellulose, carbomer, xanthan gum, sodium acrylate/sodium acryloyldimethyl taurate copolymer, polyacrylate crosspolymer-6, ammonium acryloyldimethyl taurate/behenyl polyether-25 methacrylate crosspolymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sclerotium gum, carrageen powder, agarose. The addition amount of the thickening agent is 0.1-2.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises an emollient comprising one or more of cetostearyl alcohol, squalane, isopropyl palmitate, ethylhexyl palmitate, dimethicone, cyclomethicone, octyl methicone, caprylic/capric triglyceride, isocetyl, mineral oil, oat kernel oil, octyldodecanol, avocado oil, emu oil, isopropyl myristate, saffiower oil, neopentyl glycol dicaprylate/dicaprate. The addition amount of the emollient is 1.0-30.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a humectant comprising one or more of glycerin, butylene glycol, 1, 3-propanediol, betaine, dipropylene glycol, glyceryl polyether-26, erythritol, methyl propylene glycol, hydroxyethyl urea, sodium polyglutamate, panthenol, levan, trehalose. The adding amount of the humectant is 5.0-20.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a skin conditioning agent comprising one or more of bisabolol, tocopherol, beta-glucan, niacinamide, bioglycan-1, glycerol glucoside, polyquaternium-51, glutathione, saccharide isomerate, purslane extract, avenin, acetyl chitosamine, a lactic acid bacteria fermentation lysate, a yeast dehiscence lysate. The addition amount of the skin conditioner is 3.0-10.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a ph modifier comprising one or more of triethanolamine, potassium hydroxide, arginine, sodium hydroxide, citric acid, sodium citrate. The added amount of the ph regulator is 0.1-0.6% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a preservative comprising one or more of methylparaben, propylparaben, chlorphenesin, phenoxyethanol, ethylhexylglycerin, hexamidine dihydrochloride, benzyl alcohol. The addition amount of the preservative is 0.1-1.0% by mass of the anti-aging composition.
In a further embodiment of the present invention, the anti-aging composition further comprises a solvent, wherein the solvent comprises one or more of water and ethanol. Convenient material obtaining and low cost. And the addition amount of the solvent is the balance of the total addition amount in percentage by mass of the anti-aging composition.
The invention reasonably mixes the extract of the seeds of the Spanish sage and the isosorbide dimethyl ether according to a specific proportion to obtain the anti-aging composition which is applied to cosmetics. The salvia miltiorrhiza bunge seed extract is rich in macromolecular polysaccharide, has remarkable moisturizing and repairing effects, and can strengthen the skin barrier function and delay skin aging. The macromolecular polysaccharide has good film forming property, but is difficult to be absorbed through skin, and the absorption degree limits the efficacy of the product. The dimethyl isosorbide can enhance the delivery capacity of other ingredients in the cosmetic formula, thereby enhancing the using effect of the cosmetic. Under the compound formula provided by the invention, the isosorbide dimethyl ether can promote the transdermal absorption of the spanish sage seed extract and enhance the repairing and anti-aging effects of the spanish sage seed extract. Meanwhile, the isosorbide dimethyl ether is colorless and odorless liquid, and can not cause the skin care product smeared on the skin to generate bad smell and influence the skin color. The anti-aging composition can be applied to various anti-aging cosmetic product forms, and has the characteristics of simple preparation method, wide application and capability of meeting market requirements.
In another aspect, the present invention provides a method for preparing an anti-aging composition, comprising the step of mixing the components of the anti-aging composition.
The invention also provides application of the anti-aging composition in skin care products, wherein the skin care products comprise aqueous skin care products, gel skin care products, emulsion skin care products or cream skin care products.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
Embodiments of the present invention will be described in detail below with reference to examples 1 to 3 and comparative examples 1 to 3, but those skilled in the art will understand that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention. Those whose specific conditions are not specified in the examples are carried out according to the conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
According to the content of each component in the following table 1, the anti-aging essences of the examples 1 to 3 and the comparative examples 1 to 3 are prepared according to the total weight part.
TABLE 1
The preparation method of the anti-aging essence in the above examples 1 to 3 and comparative examples 1 to 3 includes the following steps:
(1) accurately weighing various raw materials in the formula, and placing the raw materials in a clean and sterilized vessel;
(2) adding phase A raw materials (water, hydrogenated lecithin, sucrose stearate, docosyl PEG-20 esters, sclerotium rolfsii gum, methyl hydroxybenzoate, agarose, dipropylene glycol and methyl propylene glycol) into a vacuum emulsifying pot, stirring and heating to 80-85 ℃, fully and uniformly stirring, and keeping the temperature for later use;
(3) adding B-phase raw materials (isomeric hexadecane, squalane, bisabolol and octyl dodecanol) into an oil pan, stirring and heating to 80-85 ℃, fully and uniformly stirring, and keeping the temperature for later use;
(4) pumping the phase B raw material into a vacuum emulsifying pot, mixing and stirring uniformly, homogenizing and emulsifying for 5-8 minutes, fully stirring uniformly, stirring at constant temperature for defoaming for 10 minutes, and cooling;
(5) cooling to below 40 deg.C, adding C phase raw materials (tocopherol, erythritol, arginine, biogel-1, Spanish sage seed extract, and isosorbide dimethyl ether), stirring, and cooling;
(6) cooling to below 35 deg.C, adding D phase material (benzyl alcohol), stirring, discharging, and standing;
(7) after the inspection is qualified, filling, packaging and code spraying are carried out;
(8) and warehousing after the inspection is qualified.
Physical and chemical index detection
And testing the physical and chemical indexes of the anti-aging essence prepared by the method according to QB/T2660. The results are as follows:
1. appearance: white or yellowish translucent mucus.
2. pH value: 5.5-6.8.
3. And (3) investigating heat resistance stability: keeping the temperature at (40 +/-1) ℃ for 24h, and ensuring that no obvious character difference exists between the temperature after the temperature is restored to the room temperature and the temperature before the test, so that the product is qualified.
4. And (3) cold resistance stability investigation: keeping the temperature at (5 +/-1) ℃ for 24h, and ensuring that no obvious character difference exists between the temperature after the temperature is restored to the room temperature and the temperature before the test, so that the product is qualified.
Application performance detection
1) And (3) product safety test:
the anti-aging essences prepared in examples and comparative examples were subjected to a human body patch test according to the method described in technical specifications for cosmetic safety (2015 th).
The experimental population is as follows: total 36, 30 women, 6 men, age 21-59, 6 per group, composite subject volunteer enrollment criteria;
the test method comprises the following steps: the selection area is not more than 50mm2And a suitable spot tester with a depth of about 1mm, and adding about 0.020-0.025 mL of the test object into the spot tester by a closed spot test method. The plaque test device is pasted on the curved side of the forearm of a subject, the subject is removed after 24 hours, the skin reaction is observed after 0.5 hour, 24 hours and 48 hours after the removal respectively, and the result is recorded according to the skin reaction grading standard in technical Specification for cosmetic safety (2015 edition).
And (3) test results: the 36 subjects scored 0 at 3 observation time points 0.5h, 24h, 48h after removal of the patch (negative response).
2) And (3) product efficacy test:
the anti-aging essence prepared by the method is subjected to efficacy tests, including skin texture tests and skin anti-wrinkle experiments, and the specific scheme is as follows:
skin texture test
(1) The anti-aging essence prepared in the examples 1 to 3 and the comparative examples 1 to 3 is taken.
(2) The left and right cheekbones of the face, the left and right cheeks at the intersection of the nose tip and the pupil, and the left and right sides at the intersection of the temple and the mouth corner of the subject were selected as the test regions.
(3) Skin texture was first determined by a technician using a Skin image analysis system (Skin visualizer SV600) at the experimental site prior to application of the example and comparative cosmetics five times per spot and averaged.
(4) Subjects after four weeks of continuous use of the example or comparative example cosmetics, Skin texture was tested using the Skin image analysis system (Skin visualizer SV 600).
(5) The number of each measurement at the test site of the subject was counted, and the change law of skin texture was analyzed, thereby determining the efficacy of the example and comparative example cosmetics for the improvement of skin texture. (Each subject was measured by the same technician each time.)
3) Anti-wrinkle experiment on human skin
The anti-wrinkle test of human skin is the most direct method for testing the anti-wrinkle effect.
The changes in the elasticity values of the applied areas were measured by a test population using the example and comparative cosmetics and then using a skin elasticity tester (current meter dual MPA580) under the direction of the skilled person. (Each subject was measured by the same technician each time.)
(1) Take the example and comparative example cosmetics.
(2) The left and right cheekbones of the face, the left and right cheeks at the intersection of the nose tip and the pupil, and the left and right sides at the intersection of the temple and the mouth corner of the subject were selected as the test regions.
(3) The gel is applied twice a day in the morning and at night, and the photo before application is used as a control. During the experiment, the subject was unable to apply any other cosmetic.
(4) After the subjects continued to use the example and comparative example cosmetics for four weeks, the skin elasticity values before and after use were counted.
(5) And counting the values measured at each time of the experimental part of the subject, and analyzing the skin elasticity change rule of the subject to evaluate the skin elasticity change condition of the subject.
The test population: 90 wrinkled persons with the average age of 35-45 years old. Among them, 30 men and 60 women had no damage to their skin. Each of the examples and comparative examples had 15 subjects.
After four weeks (28 days) of use of the product, the data are shown in tables 2 and 3.
Test data: after four weeks (28 days) of use of the product, the statistics are shown in table 2:
TABLE 2
TABLE 3
From the above results, it can be seen that the cosmetics of comparative examples 1 to 3 do not contain 1 or more components of the antiaging composition, and the subjects showed general improvement in skin elasticity and texture after 4 weeks of use, whereas the subjects of examples 1 to 3 showed significant improvement in skin elasticity and texture after 4 weeks of use, indicating that the antiaging effect of the product was significantly improved.
In conclusion, the anti-aging composition is obtained by reasonably mixing the extract of the seeds of the Spanish sage and the isosorbide dimethyl ether according to a specific proportion, and is applied to cosmetics. The extract of the Spanish sage seed is rich in macromolecular polysaccharide, has remarkable moisturizing and repairing effects, and can strengthen the barrier function of skin and delay skin aging. The macromolecular polysaccharide has good film forming property, but is difficult to be absorbed through skin, and the absorption degree limits the efficacy of the product. The dimethyl isosorbide can enhance the delivery capacity of other ingredients in the cosmetic formula, thereby enhancing the use effect of the cosmetic. Under the compound scheme provided by the invention, the isosorbide dimethyl ether can promote the transdermal absorption of the extract of the spanish sage seeds and enhance the repairing and anti-aging effects of the extract of the spanish sage seeds. Meanwhile, the isosorbide dimethyl ether is colorless and odorless liquid, so that the skin care product applied on the skin cannot generate unpleasant odor and influence the skin color. The anti-aging composition can be applied to various anti-aging cosmetic product forms, and has the characteristics of simple preparation method, wide application and capability of meeting market demands.
The above description is only a preferred embodiment of the present invention, and not intended to limit the scope of the present invention, and all equivalent structural changes made by using the contents of the present specification or other related technical fields directly/indirectly under the inventive concept are included in the scope of the present invention.
The above description of the embodiments is only intended to facilitate an understanding of the method of the invention and its core ideas. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. An anti-aging composition, which comprises the following components in percentage by mass: 1-10% of Spanish sage seed extract and 1-5% of isosorbide dimethyl ether.
2. The anti-aging composition according to claim 1, further comprising an emulsifier comprising one or more of polyglycerol-10 dipalmitate, hydrogenated lecithin, PEG-20 behenate, potassium cetyl phosphate, ceteareth-20, sucrose stearate, polysorbate-60, polysorbate-20, PEG-40 hydrogenated castor oil, PEG-50 hydrogenated castor oil, glyceryl caprylate/caprate polyglycerol-10 esters.
3. The anti-aging composition of claim 1, further comprising a thickener comprising one or more of hydroxyethylcellulose, carbomer, xanthan gum, sodium acrylate/sodium acryloyldimethyl taurate copolymer, polyacrylate crosspolymer-6, ammonium acryloyldimethyl taurate/behenyl polyether-25 methacrylate crosspolymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, sclerosant, Chondrus crispus powder, agarose.
4. The anti-aging composition according to claim 1, further comprising an emollient comprising one or more of cetostearyl alcohol, squalane, isopropyl palmitate, ethylhexyl palmitate, dimethicone, cyclomethicone, octyl methicone, caprylic/capric triglyceride, isocetyl hexadecane, mineral oil, oat kernel oil, octyl dodecanol, avocado oil, emu oil, isopropyl myristate, saffron oil, neopentyl glycol dicaprylate/dicaprate.
5. The anti-aging composition according to claim 1, further comprising a humectant comprising one or more of glycerin, butylene glycol, 1, 3-propanediol, betaine, dipropylene glycol, glyceryl polyether-26, erythritol, methyl propanediol, hydroxyethyl urea, sodium polyglutamate, panthenol, levan, trehalose.
6. The anti-aging composition according to claim 1, further comprising a skin conditioning agent comprising one or more of bisabolol, tocopherol, beta-glucan, niacinamide, bioglycan-1, glycerol glucoside, polyquaternium-51, glutathione, saccharide isomerate, purslane extract, avenin, acetyl chitosamine, lactic acid bacteria fermentation lysate, yeast dehiscence lysate.
7. The anti-aging composition according to claim 1, further comprising a ph modifier comprising one or more of triethanolamine, potassium hydroxide, arginine, sodium hydroxide, citric acid, sodium citrate.
8. The anti-aging composition of claim 1, further comprising a preservative comprising one or more of methylparaben, propylparaben, chlorphenesin, phenoxyethanol, ethylhexylglycerin, hexamidine dihydrochloride, benzyl alcohol.
9. A method of preparing the antiaging composition according to any one of claims 1 to 8, characterized in that the preparation method comprises a step of mixing the components of the antiaging composition.
10. Use of the anti-aging composition according to any one of claims 1 to 8 in skin care products, including aqueous, gel, emulsion or cream type skin care products.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011555137.5A CN112741789A (en) | 2020-12-24 | 2020-12-24 | Anti-aging composition, preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011555137.5A CN112741789A (en) | 2020-12-24 | 2020-12-24 | Anti-aging composition, preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112741789A true CN112741789A (en) | 2021-05-04 |
Family
ID=75645855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011555137.5A Pending CN112741789A (en) | 2020-12-24 | 2020-12-24 | Anti-aging composition, preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112741789A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113679651A (en) * | 2021-09-30 | 2021-11-23 | 河南董欣生物科技有限公司 | Anti-aging composition, preparation method and application |
| CN114306112A (en) * | 2021-12-28 | 2022-04-12 | 广州雅纯化妆品制造有限公司 | Anti-aging composition and preparation method thereof |
| CN114748387A (en) * | 2022-04-25 | 2022-07-15 | 荣成市慧海创达生物科技有限公司 | Whitening and skin moistening emulsion |
| CN114903812A (en) * | 2021-06-17 | 2022-08-16 | 深圳市护家科技有限公司 | Special-moistening repair cream and preparation method thereof |
| CN115154373A (en) * | 2022-08-05 | 2022-10-11 | 广州夕木生物科技有限公司 | Anti-aging composition and preparation method thereof |
| CN115634189A (en) * | 2022-11-04 | 2023-01-24 | 肽源（广州）生物科技有限公司 | Bifidobacterium fermentation product lysate and preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011109139A2 (en) * | 2010-03-01 | 2011-09-09 | Access Business Group International Llc | Skin whitening composition containing chia seed extract |
| JP2012111727A (en) * | 2010-11-26 | 2012-06-14 | Shiseido Co Ltd | Cell activator |
| KR20160114980A (en) * | 2015-03-25 | 2016-10-06 | (주)모아캠 | Cosmetic composition comprising protein-polysaccharide extracted from linum usitatissimum seed, protein-polysaccharide extracted from salvia hispanica seed and polyglutamic acid, and method of preparing the same |
| CN106726769A (en) * | 2016-12-27 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | A kind of peony seed oil anti-apolexis composition and preparation method thereof |
| CN107106480A (en) * | 2014-10-28 | 2017-08-29 | 路博润先进材料公司 | Cosmetic composition containing Halomonas extractive from fermentative and application thereof |
| CN111514075A (en) * | 2020-06-03 | 2020-08-11 | 北京斯利安药业有限公司 | Sunscreen composition and application thereof |
| CN112080543A (en) * | 2020-09-26 | 2020-12-15 | 张超科 | Plant-derived polypeptide with anti-aging effect, facial cream containing plant-derived polypeptide and preparation method of facial cream |
-
2020
- 2020-12-24 CN CN202011555137.5A patent/CN112741789A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011109139A2 (en) * | 2010-03-01 | 2011-09-09 | Access Business Group International Llc | Skin whitening composition containing chia seed extract |
| JP2012111727A (en) * | 2010-11-26 | 2012-06-14 | Shiseido Co Ltd | Cell activator |
| CN107106480A (en) * | 2014-10-28 | 2017-08-29 | 路博润先进材料公司 | Cosmetic composition containing Halomonas extractive from fermentative and application thereof |
| KR20160114980A (en) * | 2015-03-25 | 2016-10-06 | (주)모아캠 | Cosmetic composition comprising protein-polysaccharide extracted from linum usitatissimum seed, protein-polysaccharide extracted from salvia hispanica seed and polyglutamic acid, and method of preparing the same |
| CN106726769A (en) * | 2016-12-27 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | A kind of peony seed oil anti-apolexis composition and preparation method thereof |
| CN111514075A (en) * | 2020-06-03 | 2020-08-11 | 北京斯利安药业有限公司 | Sunscreen composition and application thereof |
| CN112080543A (en) * | 2020-09-26 | 2020-12-15 | 张超科 | Plant-derived polypeptide with anti-aging effect, facial cream containing plant-derived polypeptide and preparation method of facial cream |
Non-Patent Citations (3)
| Title |
|---|
| 佚名: "Phytofuse Rejuvenate奇亚籽复苏因子", 《HTTPS://MAX.BOOK118.COM/HTML/2018/0519/167297127.SHTM》 * |
| 海淘族: "异山梨醇酐二甲醚在护肤化妆品中的功效与作用", 《HTTPS://WWW.KQMMM.COM/COSMETIC/206913.HTML》 * |
| 相启森等: "奇亚籽提取物体外抗氧化活性研究", 《食品与发酵工业》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114903812A (en) * | 2021-06-17 | 2022-08-16 | 深圳市护家科技有限公司 | Special-moistening repair cream and preparation method thereof |
| CN113679651A (en) * | 2021-09-30 | 2021-11-23 | 河南董欣生物科技有限公司 | Anti-aging composition, preparation method and application |
| CN114306112A (en) * | 2021-12-28 | 2022-04-12 | 广州雅纯化妆品制造有限公司 | Anti-aging composition and preparation method thereof |
| CN114306112B (en) * | 2021-12-28 | 2024-02-20 | 广州雅纯化妆品制造有限公司 | Anti-aging composition and preparation method thereof |
| CN114748387A (en) * | 2022-04-25 | 2022-07-15 | 荣成市慧海创达生物科技有限公司 | Whitening and skin moistening emulsion |
| CN114748387B (en) * | 2022-04-25 | 2024-05-14 | 荣成市慧海创达生物科技有限公司 | Whitening and skin-moistening emulsion |
| CN115154373A (en) * | 2022-08-05 | 2022-10-11 | 广州夕木生物科技有限公司 | Anti-aging composition and preparation method thereof |
| CN115634189A (en) * | 2022-11-04 | 2023-01-24 | 肽源（广州）生物科技有限公司 | Bifidobacterium fermentation product lysate and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112741789A (en) | Anti-aging composition, preparation method and application | |
| CN110302101B (en) | Moisturizing repair emulsion and preparation method thereof | |
| CN113041190B (en) | Antioxidant composition, preparation method and application | |
| CN112641687A (en) | Whitening composition, preparation method and application | |
| CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
| CN109394653A (en) | A kind of stoste and preparation method thereof | |
| CN110575412A (en) | a special skin caring liquid for pore containing medicinal extract of Fomitopsis pinicola layer, and its preparation method | |
| CN111568830A (en) | Skin care composition and preparation method thereof | |
| CN111658555A (en) | Nano anti-wrinkle essence cream and preparation method thereof | |
| CN113384497B (en) | Composition and cosmetic for double moisturizing, repairing and improving skin elasticity | |
| CN114224764A (en) | Bath lotion composition suitable for various surface active systems and preparation process thereof | |
| CN111419744A (en) | Anti-saccharification skin cream and preparation method thereof | |
| CN115887322B (en) | Whitening and freckle removing, skin smoothing and moisturizing essence and preparation method thereof | |
| CN112891278B (en) | Whitening composition, preparation method and application | |
| JP2019202996A (en) | COSMETIC COMPOSITION COMPRISING γ-POLYGLUTAMIC ACID AS ACTIVE COMPONENT | |
| CN113749972B (en) | Composition with anti-wrinkle effect and application of composition in cosmetics | |
| CN109453088A (en) | Compact frost of whitening and preparation method thereof and tyrosinase inhibitor | |
| CN104922004B (en) | A kind of plant moisturizing skin care compositions and its application in cosmetics | |
| CN113679651A (en) | Anti-aging composition, preparation method and application | |
| CN112618422A (en) | Composite whitening composition, preparation method and application | |
| CN114469811A (en) | Collagen anti-wrinkle repair mask and production process | |
| CN114099388A (en) | Anti-wrinkle composition and preparation method and application thereof | |
| CN113577006A (en) | Anti-wrinkle eye cream and preparation method thereof | |
| CN113304067A (en) | Moisturizing composition and preparation method and application thereof | |
| CN114668682B (en) | Moisturizing and skin-brightening composition and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210504 |